Format

Send to

Choose Destination
Pharmacol Res. 2016 Nov;113(Pt A):592-599. doi: 10.1016/j.phrs.2016.09.041. Epub 2016 Sep 30.

Berberine and inflammatory bowel disease: A concise review.

Author information

1
Pharmacognosy Research Laboratories, University of Greenwich, Chatham-Maritime, Kent ME4 4TB, UK; Herbal Analysis Services, UK. Electronic address: s.habtemariam@herbalanalysis.co.uk.

Abstract

Berberine is the principal component of many popular medicinal plants (e.g. the genus Berberis, Coptis and Hydrastis among others) with a history of thousands of years of usage in traditional medicine. The numerous pharmacological activities of berberine reported in the last two decades have been attracting high level interests both within the scientific community, clinicians and the public at large. Despite enormous amount of efforts have been placed to show its therapeutic value for inflammatory bowel diseases (IBD), however, comprehensive up-to-date review article in this field is not yet available. In this communication, literature data from in vitro and in vivo experiments were scrutinised and concisely presented to demonstrate its anti-IBD potential. Beyond the known general antioxidant and anti-inflammatory effects of berberine, IBD-specific effects including gut epithelial barrier pathology, T cells as emerging targets, antinociceptive and other effects are discussed.

KEYWORDS:

Anti-diarrhoeal; Anti-inflammatory mechanisms; Antinociceptive; Berberine; Epithelial barrier protection; Inflammatory bowel disease

PMID:
27697643
DOI:
10.1016/j.phrs.2016.09.041
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center